Margaret Haney, PhD

Nov 13, 2025 01:00 PM MST

Cannabis Misuse and Therapeutic Potential: Placebo-controlled Laboratory Studies

Dr. Margaret (Meg) Haney is a Professor of Neurobiology (in Psychiatry) at the Columbia University Irving Medical Center. As the Director of the Cannabis Research Laboratory and of the Substance Use Research Center in the Division of Substance Use Disorders, Dr. Haney is internationally recognized for her expertise in cannabis and cannabinoids. Her current work focuses on: (1) conducting placebo-controlled studies testing the efficacy of potential treatment medications for Cannabis Use Disorder, and (2) testing the potential therapeutic effects of cannabis and its constituents for a range of indications, including pain and appetite-enhancement. Dr. Haney’s research has been continuously supported by the National Institute of Health (NIH) since 1999. She has authored over 180 scientific publications, is an Associate Editor for Cannabis and Cannabinoid Research, is an Advisory Editor for Psychopharmacology, and co-edited Neuropsychopharmacology Reviews 2018, Cannabis and Cannabinoids: From Synapse to Society. Dr. Haney has been a longstanding participant in NIH review groups and has been on several NIH advisory councils, is an elected Fellow at the American College of Neuropsychopharmacology and is a past President of the College on Problems of Drug Dependence (2019). Her contributions to research have been recognized by both the Center for Medicinal Cannabis Research and the College on Problems of Drug Dependence.

Register here

Previous Webinars

Nolan Kane, PhD.

Genetics, chemistry and the evolution of sex chromosomes in Cannabis

May 21, 2025 11:00 AM MST

Dr. Nolan Kane is an associate professor in the ebio department at the university of Colorado, boulder. he uses genomic approaches to study adaptation to new environments, domestication of wild plants into valuable crops, and the formation of new species. his work has […]

Read More »

Andrew Kesner, PhD

Preclinical modeling of spontaneous Δ-9-THC withdrawal symptoms in mice: sleep, dopamine, and behavioral maladaptations

April 10th, 1:00PM MST

Dr. Kesner is the Chief of the Unit on Motivation and Arousal at National Institute on Alcohol Abuse and Alcoholism (NIAAA). The mission of his lab is to use systems neuroscience approaches to understand how brain systems controlling motivated […]

Read More »

Roberta Paris, PhD.

Genetic, molecular and biochemical studies on the accumulation of bioactive compounds in Cannabis sativa L.

19 March, 2025, 11:00 AM  

Dr. Roberta Paris studied at the Alma Mater Studiorum, University of Bologna, where she obtained the PhD in Cellular and Molecular Biology in 2006. She is a permanent researcher at Council for Agricultural Research and Economic, Research […]

Read More »

Sarah D. Lichenstein, PhD.

Neural mechanisms of risk for problem-level cannabis use among emerging adults

Dr. Lichenstein is a licensed clinical psychologist, an Assistant Professor of Psychiatry, and Assistant Director of the Yale Imaging and Psychopharmacology Lab at Yale School of Medicine. She received her BA in Psychology from Bard College (2008), and her PhD in Clinical Psychology from the […]

Read More »

Kevin Boehnke, PHD.

January 9th at 1:00PM MST

Thoughtful approaches to chronic pain and cannabis research

Dr. Kevin Boehnke is an Assistant Professor in the Department of Anesthesiology and the Chronic Pain and Fatigue Research Center. Kevin received his doctorate from the University of Michigan School of Public Health in Environmental Health Sciences in 2017. He is also a […]

Read More »

David Gorelick, MD, PHD.

December 12th at 1:00PM MST

Cannabis-related psychiatric disorders

Dr. David Gorelick earned his bachelor degree in psychology from Cornell University and his medical degree and PhD in pharmacology from Albert Einstein College of Medicine. After completing his psychiatry residency at UCLA, he remained on the faculty until 1989, when he moved to the NIDA Intramural Research […]

Read More »